These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8503411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The compositional abnormalities of lipoproteins in diabetic renal failure.
    Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P.
    Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
    [Abstract] [Full Text] [Related]

  • 4. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO, Alaupovic P, Tavella M, Knight-Gibson C.
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and classification of dyslipidemia in renal disease.
    Attman PO, Samuelsson O, Alaupovic P.
    Blood Purif; 1996 Jan; 14(1):49-57. PubMed ID: 8718566
    [Abstract] [Full Text] [Related]

  • 6. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO, Samuelsson O, Alaupovic P.
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [Abstract] [Full Text] [Related]

  • 7. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO, Alaupovic P.
    Nephron; 1991 Dec; 57(4):401-10. PubMed ID: 2046821
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 9. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T, Krane V, Metzger T, Wanner C.
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [Abstract] [Full Text] [Related]

  • 10. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Weiss L, Alaupovic P.
    J Am Soc Nephrol; 1998 Aug; 9(8):1482-8. PubMed ID: 9697671
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein abnormalities in chronic renal failure and dialysis patients.
    Monzani G, Bergesio F, Ciuti R, Rosati A, Frizzi V, Serruto A, Vitali D, Benucci A, Tosi PL, Bandini S, Salvadori M.
    Blood Purif; 1996 Aug; 14(3):262-72. PubMed ID: 8738541
    [Abstract] [Full Text] [Related]

  • 12. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH, Glickman RM, Saudek CD, Blum CB, Tall AR.
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [Abstract] [Full Text] [Related]

  • 13. Dyslipoproteinemia in diabetic renal failure.
    Attman PO, Nyberg G, William-Olsson T, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1992 Dec; 42(6):1381-9. PubMed ID: 1474769
    [Abstract] [Full Text] [Related]

  • 14. The effect of decreasing renal function on lipoprotein profiles.
    Attman PO, Samuelsson O, Alaupovic P.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 16. Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P.
    Nephrol Dial Transplant; 1994 Apr; 9(11):1580-5. PubMed ID: 7870346
    [Abstract] [Full Text] [Related]

  • 17. [Lipid metabolism abnormalities in Chronic Kidney Disease].
    Bianchi S, Baronti A, Cominotto R, Bigazzi R.
    G Ital Nefrol; 1994 Apr; 33(S68):. PubMed ID: 27960010
    [Abstract] [Full Text] [Related]

  • 18. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
    Vaziri ND.
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F262-72. PubMed ID: 16403839
    [Abstract] [Full Text] [Related]

  • 19. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 20. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH.
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.